Can you get Mounjaro on the NHS?

Yes—Mounjaro (tirzepatide) can be prescribed on the NHS, but access is being phased and is currently limited to people with the highest clinical need under national criteria set by NHS England and NICE. As of June 2025, initial access is through specialist services and selected GP pathways, prioritising adults with very high BMI and multiple weight-related health conditions, with strict eligibility and clinical assessment requirements. This staged rollout is part of a multi-year plan to safely expand availability across England, with timing and local service readiness varying by area. For now, most people will not be eligible unless they meet the priority criteria defined in NHS guidance and NICE recommendations.

• Mounjaro can be prescribed on the NHS under NICE guidance, with NHS England phasing access over time.
• Early access focuses on those with the greatest clinical need, typically very high BMI plus multiple related conditions.
• Initial rollout began in 2025 via specialist weight management services and selected GP pathways.
• Local availability depends on service setup and commissioning in each area.
• Eligibility and prescribing require clinical assessment and adherence to NHS/NICE pathways.

Sources

• NHS England – Medicines for obesity: weight management injections
• NICE Technology Appraisal TA1026 – Tirzepatide for managing overweight and obesity
• NHS England – Interim commissioning guidance for tirzepatide implementation
• South West London ICB – Tirzepatide position statement
• Cheshire & Merseyside – Tirzepatide formulary statement